Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
118.64
+0.35 (0.30%)
At close: Sep 18, 2024, 4:00 PM
118.97
+0.33 (0.28%)
After-hours: Sep 18, 2024, 7:25 PM EDT

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of $300.73 billion. The enterprise value is $327.23 billion.

Market Cap 300.73B
Enterprise Value 327.23B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024, before market open.

Earnings Date Oct 24, 2024
Ex-Dividend Date Sep 16, 2024

Share Statistics

Merck & Co. has 2.53 billion shares outstanding. The number of shares has increased by 0.28% in one year.

Shares Outstanding 2.53B
Shares Change (YoY) +0.28%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.07%
Owned by Institutions (%) 78.62%
Float 2.53B

Valuation Ratios

The trailing PE ratio is 22.03 and the forward PE ratio is 13.90. Merck & Co.'s PEG ratio is 0.33.

PE Ratio 22.03
Forward PE 13.90
PS Ratio 4.81
Forward PS 4.41
PB Ratio 6.90
P/FCF Ratio 22.87
PEG Ratio 0.33
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.85, with an EV/FCF ratio of 24.89.

EV / Earnings 23.82
EV / Sales 5.24
EV / EBITDA 13.85
EV / EBIT 16.56
EV / FCF 24.89

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.87.

Current Ratio 1.47
Quick Ratio 0.93
Debt / Equity 0.87
Debt / EBITDA 1.58
Debt / FCF 2.87
Interest Coverage 15.94

Financial Efficiency

Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 15.73%.

Return on Equity (ROE) 33.38%
Return on Assets (ROA) 11.38%
Return on Capital (ROIC) 15.73%
Revenue Per Employee $867,778
Profits Per Employee $190,778
Employee Count 72,000
Asset Turnover 0.58
Inventory Turnover 2.44

Taxes

In the past 12 months, Merck & Co. has paid $1.50 billion in taxes.

Income Tax 1.50B
Effective Tax Rate 9.82%

Stock Price Statistics

The stock price has increased by +10.04% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change +10.04%
50-Day Moving Average 118.47
200-Day Moving Average 122.19
Relative Strength Index (RSI) 56.08
Average Volume (20 Days) 8,439,121

Short Selling Information

The latest short interest is 25.91 million, so 1.02% of the outstanding shares have been sold short.

Short Interest 25.91M
Short Previous Month 26.72M
Short % of Shares Out 1.02%
Short % of Float 1.02%
Short Ratio (days to cover) 2.47

Income Statement

In the last 12 months, Merck & Co. had revenue of $62.48 billion and earned $13.74 billion in profits. Earnings per share was $5.39.

Revenue 62.48B
Gross Profit 47.35B
Operating Income 19.77B
Pretax Income 15.23B
Net Income 13.74B
EBITDA 23.63B
EBIT 19.77B
Earnings Per Share (EPS) $5.39
Full Income Statement

Balance Sheet

The company has $11.35 billion in cash and $37.79 billion in debt, giving a net cash position of -$26.43 billion or -$10.43 per share.

Cash & Cash Equivalents 11.35B
Total Debt 37.79B
Net Cash -26.43B
Net Cash Per Share -$10.43
Equity (Book Value) 43.65B
Book Value Per Share 17.19
Working Capital 12.15B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $16.69 billion and capital expenditures -$3.54 billion, giving a free cash flow of $13.15 billion.

Operating Cash Flow 16.69B
Capital Expenditures -3.54B
Free Cash Flow 13.15B
FCF Per Share $5.19
Full Cash Flow Statement

Margins

Gross margin is 75.79%, with operating and profit margins of 31.64% and 21.98%.

Gross Margin 75.79%
Operating Margin 31.64%
Pretax Margin 24.41%
Profit Margin 21.98%
EBITDA Margin 37.82%
EBIT Margin 31.64%
FCF Margin 21.04%

Dividends & Yields

This stock pays an annual dividend of $3.08, which amounts to a dividend yield of 2.60%.

Dividend Per Share $3.08
Dividend Yield 2.60%
Dividend Growth (YoY) 5.48%
Years of Dividend Growth 14
Payout Ratio 57.18%
Buyback Yield -0.28%
Shareholder Yield 2.32%
Earnings Yield 4.57%
FCF Yield 4.37%
Dividend Details

Analyst Forecast

The average price target for Merck & Co. is $134.58, which is 13.44% higher than the current price. The consensus rating is "Buy".

Price Target $134.58
Price Target Difference 13.44%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 5.98%
EPS Growth Forecast (5Y) 146.04%
Stock Forecasts

Stock Splits

The last stock split was on February 17, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Feb 17, 1999
Split Type Forward
Split Ratio 2:1

Scores

Merck & Co. has an Altman Z-Score of 4.57 and a Piotroski F-Score of 7.

Altman Z-Score 4.57
Piotroski F-Score 7